Health Canada Authorizes Clinical Trial for Cellulose-Based Dermal Filler
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.
A study found increases in collagen, elastin, and other extracellular matrix proteins following Radiesse treatment, along with improvements in markers of solar elastosis, a sign of sun-damaged skin.